Sight Sciences Inc (NAS:SGHT)
$ 3.9 -0.01 (-0.26%) Market Cap: 197.06 Mil Enterprise Value: 117.81 Mil PE Ratio: 0 PB Ratio: 2.07 GF Score: 75/100

Sight Sciences Inc at Citi Healthcare & Medtech Conference Transcript

Mar 01, 2023 / 08:30PM GMT
Release Date Price: $11 (+0.18%)
Joanne Wuensch
Citigroup Inc. - Analyst

We're going again. I'm Joanne Wuensch. I'm a medical technology analyst here. And we have the management of Sight Sciences with us. So thank you all for joining us.

Paul Badawi
Sight Sciences, Inc. - CEO

Thanks for having us, Joanne.

Questions & Answers

Joanne Wuensch
Citigroup Inc. - Analyst

So I need to start big picture. And let's start with the MIGS market and the landscape. And how you see evolving, and maybe we'll call it, a post-pandemic environment?

Paul Badawi
Sight Sciences, Inc. - CEO

Yeah. We're super excited about the market. There's the combo cataract segments that's growing nicely. We're continuing to take share in that segment. We're expanding the combo cataract segment in the market to advanced space. And then there's the much larger standalone opportunity, four to five times larger.

We're developing that market. We've got a unique indication for use, a unique usability and efficacy profile

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot